Fractyl Health
Fractyl Health is an organ editing metabolic therapeutics company focused on pioneering a new approach to the treatment of Type 2 Diabetes (T2D). Our goal is to transform T2D treatment from chronic blood glucose management to disease-modifying therapies that target the organ-level root causes of metabolic disease. We have assembled a mission-driven team full of innovators, united in a passion to eradicate type 2 diabetes and to develop breakthrough therapies—the type of therapies we would want for our family members and loved ones with the disease. Through our accomplished board of directors, investors, and scientific advisors, we have access to some of the most insightful minds in the global scientific and biopharma landscape.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
About us
Fractyl Health’s purpose is to defend humanity from the metabolic diseases of modernity. Over the past several years, we have gained a deeper understanding of the changes that occur in the gut in response to modern diets. We are singularly focused on developing therapies that are designed to target the root causes of metabolic diseases and delivering our therapies as broadly as possible to as many patients as possible as rapidly as possible.
We believe this approach will be better for patients, better for physicians and better for society. Turning the tide on type 2 diabetes is achievable, but it requires intestinal fortitude. It takes guts.